Zobrazeno 1 - 10
of 18
pro vyhledávání: '"A. N. Yavorsky"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 3, Pp 336-347 (2023)
Scientific relevance. In recent years, antimicrobial resistance in pathogenic microorganisms has become a global problem that threatens the health of humans and animals and poses a risk to the biosafety of Russia.Aim. The study aimed to analyse the p
Externí odkaz:
https://doaj.org/article/f27b745cf1c8467cbba56a49d180daa6
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 0, Iss 2, Pp 38-42 (2018)
RETRACTED ARTICLEThe present article considers the experience of a unitary expert and control authority regulating the circulation of medicines in the European Union (EU) – the European Medicines Agency. It also describes the main contents of the c
Externí odkaz:
https://doaj.org/article/80757accac0a4513ba401c9d17928f40
Autor:
A. L. Khokhlov, A. N. Yavorsky, N. O. Pozdnyakov, J. V. Rybachkova, E. S. Emelianov, A. A. Khokhlov, A. E. Miroshnikov, S. O. Pozdnyakov
Publikováno v:
Архивъ внутренней медицины, Vol 8, Iss 1, Pp 45-52 (2018)
The complexity of therapy of lipid metabolism disorders is not only in comorbidity and polypragmasia, but also in predicting a genetically determined response to the treatment. The aim of our work was to study the pharmacogenetics features of pharmac
Externí odkaz:
https://doaj.org/article/31bf942db4b14a65a049a70b29d53deb
Autor:
R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 1, Pp 7-12 (2018)
Advanced therapy medicinal products (ATMP) represent a heterogeneous group of medicinal products, combined with the need for special regulation of their circulation. ATMP is a gene therapy medicinal products, a somatic cell therapy medicinal products
Externí odkaz:
https://doaj.org/article/fb5feca2af454a389c472a4cd2c8666a
Autor:
V. K. Lepakhin, Yu. V. Olefir, V. A. Merkulov, N. D. Bunyatyan, B. K. Romanov, A. N. Yavorsky, E. M. Rychihina
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 0, Iss 1, Pp 3-10 (2018)
The article describes the landmarks of control and licensing system development for the purpose of drug evaluation, marketing authorization and circulation in Russia. The need for the development of a state institution for performing expert evaluatio
Externí odkaz:
https://doaj.org/article/b895235b9cfd49898c80f7b361989039
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 0, Iss 4, Pp 32-38 (2018)
The article presents generalized information about the program of the World Health Organization (WHO) related to International Nonproprietary Names (INN) of biological and biotechnological drugs. It reflects general principles for selecting INN for b
Externí odkaz:
https://doaj.org/article/51bbcb3c08024f9f9fd534e8312016dc
Autor:
A. A. Mokhov, A. N. Murashev, M. S. Krasilshchikova, O. N. Khokhlova, S. G. Semushina, E. A. Rasskazova, D. I. Rzhevskiy, V. S. Popov, A. N. Yavorsky
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 0, Iss 4, Pp 62-68 (2018)
The authors have analyzed international experience in creating legal documents regulating the use of animals for scientific purposes. Topical issues related to the use of laboratory animals for scientific purposes in the Russian Federation, including
Externí odkaz:
https://doaj.org/article/615d519a2a804d3eabb9ae31551a462d
Autor:
A. A. Mokhov, N. O. Pozdnyakov, A. L. Khokhlov, A. N. Yavorsky, A. E. Miroshnikov, Ph. A. Romanov
Publikováno v:
Kutafin Law Review. 8:3-35
The current science and research trends, as well as the development of personalized medicine, point to the need to use genetic tests in course of the study of pharmaceuticals. Pharmacogenetic testing has become indispensable when developing new pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b17684e6f5a13369c958a2067c0cd3c
https://doi.org/10.17803/2313-5395.2021.1.15.003-035
https://doi.org/10.17803/2313-5395.2021.1.15.003-035
Publikováno v:
Kutafin Law Review. 8:115-128
Significant progress has been made in the development of genetic technologies in recent decades. Currently, high-performance sequencing and, most importantly, genome editing technologies are widely used and available for laboratories in Russia. Exist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::467606f83d0b6f3f654b57848d582ee8
https://doi.org/10.17803/2313-5395.2021.1.15.115-128
https://doi.org/10.17803/2313-5395.2021.1.15.115-128
Autor:
A. N. Yavorsky, S. N. Orekhov
Publikováno v:
Courier of Kutafin Moscow State Law University (MSAL)). :60-73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f059c307ab6cbb3dcf53fe37dfc64e3
https://doi.org/10.17803/2311-5998.2020.69.5.060-073
https://doi.org/10.17803/2311-5998.2020.69.5.060-073